AzTrials
AzTrials

Gambling DisorderNCT05693155

Experience of the Nationwide Gambling Self-exclusion Service Spelpaus - Effects and Limitations of a Unique Harm Reduction Instrument for Problem Gambling

An observational study of Gambling Disorder and Problem Gambling, run by Region Skane at 1 site in Sweden.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Qualitative interview study addressing the effects and limitations of a unique, government-based, nationwide self-exclusion service for the reduction of gambling-related harm. This service, which allows for individuals at risk of gambling problems (and for anyone) to self-exclude from all licensed gambling in the… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Gambling Disorder, Problem Gambling
What is being tested?
Voluntary self-exclusion from gambling ('Spelpaus')
How many people
20 participants
Where
1 siteSweden
Study dates
13 Feb 2023to 31 Jul 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: 1. Patients at a gambling disorder unit, or self-recruited through social media advertising and defining as a person with a gambling problem 2. Concerned significant others of patients at a gambling disorder unit or self-recruited through social media advertising and defining as a concerned significant other of a person with a gambling problem.

Who may be able to join

  • Patient at a gambling disorder unit or self-recruited through social media advertising and defining as a person with a gambling problem, and/or concerned significant other of a patient at a gambling disorder unit or self-recruited through social media advertising and defining as a concerned significant other of a person with a gambling problem.

Who cannot join

  • Inability to provide informed study consent and to carry out a qualitative research interview, due to language difficulties and/or cognitive problems.

Trial locations and contacts

1 site in 1 country.

Anders Håkansson, PhD contact

+46 46 175596

anders_c.hakansson@med.lu.se

Johanna Tjernberg, Reg Nurse contact

+46 72 463 64 06

johanna.tjernberg@skane.se

Sweden1 site, 1 recruiting
  • Malmö Addiction Center

    Malmö

    Anders Håkansson, PhD, anders.c.hakansson@skane.se

    Recruiting

Other trials in Sweden

About this study

Qualitative interview study addressing the effects and limitations of a unique, government-based, nationwide self-exclusion service for the reduction of gambling-related harm. This service, which allows for individuals at risk of gambling problems (and for anyone) to self-exclude from all licensed gambling in the country, is unique in its nationwide, non-gambling-operator-dependent and multi-operator design. It is a promising tool for the prevention and harm reduction in relation to problem gambling and gambling disorder, but emerging research data report considerable limitations including high access to non-licensed gambling allowing users to breach the voluntary self-exclusion and relapse into hazardous gambling practices. This study will examine effects and limitations of the system, for gamblers and for concerned significant others of gamblers, through qualitative interviews addressing their experience of the system.

Being tested
Voluntary self-exclusion from gambling ('Spelpaus')
Keywords
gambling disorder, problem gambling, concerned significant others, self-exclusion, harm reduction
Medical subject headings
Gambling, Harm Reduction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Voluntary self-exclusion from gambling ('Spelpaus')Behavioural

    Voluntary self-exclusion from gambling, using the government-based, official service 'Spelpaus' (literally 'play break')

Study groups in NCT05693155
Study groupRoleWhat they receive
Individuals with a gambling problemRecruited from a gambling disorder treatment unit and/or from social media advertising addressing individuals with a gambling problem.
Receives: Behavioral: Voluntary self-exclusion from gambling ('Spelpaus')
Concerned significant othersRecruited as concerned signifiant others of patients at a gambling disorder treatment unit and/or in social media advertising addressing concerned significant others of individuals with a gambling problem.
Receives: Behavioral: Voluntary self-exclusion from gambling ('Spelpaus')

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Qualitative reporting of self-perceived effects from self-exclusion

    Subjective perception of favorable effects on gambling behavior or well-being

    Measured: Since 2019

  2. Qualitative reporting of self-perceived harm or limitations from self-exclusion

    Subjective perception of negative impact or lack of improvement with respect to gambling behavior or well-being

    Measured: Since 2019

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jan 2023
  2. Study start13 Feb 2023 (estimated)
  3. Primary completion30 Jun 2023 (estimated)
  4. Study completion31 Jul 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05693155
Sponsor's protocol ID
Spelpaus study
Status last verified
Feb 2023
First submitted
27 Dec 2022
Last updated
9 Feb 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Hakansson A, Tjernberg J, Hansson H. Effects and Limitations of a Unique, Nationwide, Self-Exclusion Service for Gambling Disorder and Its Self-Perceived Effects and Harms in Gamblers: Protocol for a Qualitative Interview Study. JMIR Res Protoc. 2023 Nov 14;12:e47528. doi: 10.2196/47528.

    PubMed 37962917

Questions about this trial

What is this clinical trial studying?

An observational study of Gambling Disorder and Problem Gambling, run by Region Skane at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Feb 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Anders Håkansson, PhD (+46 46 175596, anders_c.hakansson@med.lu.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Qualitative reporting of self-perceived effects from self-exclusion (time frame: Since 2019). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05693155, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in